semaglutide for postpartum weight loss Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds Semaglutide and Tirzepatide for Post-Pregnancy

Long-term treatment is significant

Primary endpoints included cataracts, oculomotor binocular dysfunction, visual impairment and blindness, visual disturbances, dry eye disease, and ametropic accommodative dysfunction, all identified through ICD-10-CM coding (Supplementary Data 3)

How to Recognize Symptoms of Severe Dehydration or Other Emergencies

Mulder RH, Neumann A, Cecil CAM, Walton E, Houtepen LC, Simpkin AJ, et al

Because tirzepatide (brand name Mounjaro) was only approved by the FDA in mid-2022 for type 2 diabetes, the ability to rigorously analyze its use (on- and off-label) for a broad population of patients with overweight or obesity, not just a subset captured in insurance databases, has the power to greatly improve our understanding of how these agents are being used in every day practice and the effect that theyre having.

To access these medications, adults must have a BMI of 30 or above or a BMI of 27 and a weight-related condition such as high blood pressure or sleep apnoea